Wednesday, February 27, 2013

• Vertex Enters Critical Phaseat Motley Fool (Wed, Feb 27)
• Vertex Announces Webcasts of its Presentations at Two Investor ConferencesBusiness Wire (Wed, Feb 27)
• Vertex shares pop on new cystic fibrosis drug trial launchat bizjournals.com (Wed, Feb 27)

Tuesday, February 26, 2013

• Vertex Readies Late-Stage Cystic Fibrosis Drug Studiesat TheStreet (Tue, Feb 26)
• Vertex Pharmaceuticals (VRTX): Today's Featured Drugs Laggardat TheStreet (Tue, Feb 26)
• Hepatitis C In Play for 2013?at Motley Fool (Tue, Feb 26)
• Vertex Announces Initiation of Pivotal Phase 3 Program of VX-809 in Combination with Ivacaftor for the Treatment of People with Cystic Fibrosis Who Have Two Copies of the F508del MutationBusiness Wire (Tue, Feb 26)

Friday, February 22, 2013

• What's behind put selling in VertexoptionMONSTER (Fri, Feb 22)
• This Is One Incredible CEOat Motley Fool (Fri, Feb 22)
• A Triumph In Breast Cancer -- And Another Expensive Drugat Forbes (Fri, Feb 22)

Thursday, February 21, 2013

• Vertex Pharmaceuticals Stock Sell Recommendation Reiterated (VRTX)at TheStreet (Thu, Feb 21)

Tuesday, February 19, 2013

• The FDA Made Biotech Investing Harder (But More Lucrative)at Motley Fool (Tue, Feb 19)
• Gilead Stock Hits New High As HCV Drug Keeps Rockingat Investor's Business Daily (Tue, Feb 19)

Sunday, February 17, 2013

• My Favorite Big Biotech for 2013at Motley Fool (Sun, Feb 17)

Thursday, February 14, 2013

• Vertex Pharmaceuticals (VRTX): Today's Featured Drugs Laggardat TheStreet (Thu, Feb 14)
• The Jury Is Still Out On The Risky NS5B Drugsat Seeking Alpha (Thu, Feb 14)

Wednesday, February 13, 2013

• Pharmacyclics, Johnson & Johnson Nab Breakthrough Designation for New Cancer Drugat Minyanville (Wed, Feb 13)

Tuesday, February 12, 2013

• Innovative Drugs May Win U.S. Approval After Early Trialsat Bloomberg (Tue, Feb 12)

Monday, February 11, 2013

• Fisking Ray Dirks On Medgenics And Shaming Seeking Alphaat TheStreet (Mon, Feb 11)
• Disappointing Fourth Quarter - Reason to Sell?at Motley Fool (Mon, Feb 11)
• VERTEX PHARMACEUTICALS INC / MA Files SEC form 8-K, Amendments to Articles of Inc. or Bylaws; Change in Fiscal Year,EDGAR Online (Mon, Feb 11)

Saturday, February 9, 2013

• Has Gilead Sciences Become the Perfect Stock?at Motley Fool (Sat, Feb 9)

Friday, February 8, 2013

• Robert Half CEO Sells 200K Shares and 4 Insider Sales to Know Nowat Wall St. Cheat Sheet (Fri, Feb 8)

Wednesday, February 6, 2013

• Kalydeco Funding Cleared in IrelandZacks (Wed, Feb 6)
• Guilty Until Proven Innocentat Motley Fool (Wed, Feb 6)

Add VRTX News to My Yahoo!